{"id":"W2262803926","doi":"10.3111/13696998.2016.1141780","title":"Clinical and economic benefits of extended treatment with apixaban for the treatment and prevention of recurrent venous thromboembolism in Canada","year":2016,"lang":"en","type":"article","venue":"Journal of Medical Economics","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"ca_institutions":"Bristol-Myers Squibb (Canada); Pfizer (Canada)","funders":"Bristol-Myers Squibb Canada","keywords":"Medicine; Apixaban; Venous thromboembolism; Intensive care medicine; Internal medicine; Warfarin; Atrial fibrillation; Rivaroxaban; Thrombosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00269557,0.000466111,0.0009762648,0.001030299,0.001112664,0.001330867,0.001211997,0.0005523317,0.003321708],"category_scores_gemma":[0.01121264,0.0003107536,0.002115552,0.002058692,0.0006195427,0.0003891037,0.000957522,0.001111264,0.00006704997],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.06525097,"about_ca_system_score_gemma":0.08725726,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9878884,"about_ca_topic_score_gemma":0.9888933,"domain_scores_codex":[0.9980021,0.0006987475,0.0001284688,0.00022894,0.0005158982,0.0004257912],"domain_scores_gemma":[0.9942002,0.002068782,0.0009024336,0.0001787513,0.001773128,0.0008767407],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01765426,0.0007756602,0.499858,0.005726067,0.01438949,0.001026453,0.0006113845,0.2546655,0.00114405,0.02372822,0.03270765,0.1477132],"study_design_scores_gemma":[0.009268976,0.002262233,0.5976691,0.002947876,0.02357229,0.0007186768,0.001250722,0.3179095,0.001881756,0.0117665,0.03034566,0.0004066684],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8699794,0.05789657,0.00421607,0.01396948,0.0002487252,0.0007344781,0.03320793,0.0001279041,0.01961951],"genre_scores_gemma":[0.9881989,0.006203485,0.001376553,0.000543446,0.00002921282,0.00006676622,0.002452689,0.00001111561,0.0011178],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06525097,"threshold_uncertainty_score":0.4734312,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03019685173148177,"score_gpt":0.305182404215438,"score_spread":0.2749855524839562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}